Seeing Is Believing
Currently out of the existing stock ratings of Bill Sutherland, 157 are a BUY (90.75%), 16 are a HOLD (9.25%).
Analyst Bill Sutherland, currently employed at BENCHMARK, carries an average stock price target met ratio of 25.45% that have a potential upside of 29.23% achieved within 143 days.
Bill Sutherland’s has documented 339 price targets and ratings displayed on 21 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on SEM, Select Medical Holdings at 25-Nov-2024.
Analyst best performing recommendations are on AUGX (AUGMEDIX).
The best stock recommendation documented was for OMCL (OMNICELL) at 7/15/2024. The price target of $38 was fulfilled within 17 days with a profit of $11.56 (43.72%) receiving and performance score of 25.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$101
$15.19 (17.70%)
$101
4 months 16 days ago
(31-Jul-2024)
3/10 (30%)
$2.95 (3.01%)
70
Hold
$101
$15.19 (17.70%)
$101
4 months 22 days ago
(25-Jul-2024)
1/8 (12.5%)
$3.25 (3.32%)
45
Hold
8 months 21 days ago
(26-Mar-2024)
5/10 (50%)
$12.13 (9.49%)
99
Hold
$101
$15.19 (17.70%)
$84
1 years 4 months 16 days ago
(31-Jul-2023)
1/3 (33.33%)
$10.16 (11.18%)
28
Hold
$101
$15.19 (17.70%)
$100
1 years 4 months 20 days ago
(27-Jul-2023)
0/5 (0%)
$10.5 (11.60%)
Which stock is Bill Sutherland is most bullish on?
Which stock is Bill Sutherland is most reserved on?
What Year was the first public recommendation made by Bill Sutherland?